OK Biotech Co., Ltd. (4155.TW) TAI

Currency In TWD

AD

Valuation

Market Cap2.43B
Enterprise Value3.15B
P/E Ratio8.86
PEG Ratio0.01
Price/Sales Ratio1.43
Price/Book Ratio0.85
Enterprise/Revenue1.86
Enterprise/EBITDA8.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.16
Operating Margin0.14
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.1

Income Statement

Revenue1.56B
Revenue/Share10.9
Gross Profit429.25M
EBITDA201.51M
Net Income82.45M
Diluted EPS0.57

Balance Sheet

Total Cash382.88M
Total Cash/Share2.71
Total Debt1.04B
Total Debt/Equity0.41
Current Ratio2.4
Book Value Per Share18.25

Price History

52-Week Change-2.26
52-Week High16.5
52-Week Low12.85
Moving Average 50 Days14.94
Moving Average 200 Days14.45

Statistics

Average Volume294,916
Shares Outstanding144.68M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.18
Last Split Factor112:125
Last Split DateOctober 07, 2026
AD